The global central venous catheter market size was valued at USD 2.55 billion in 2025 and is projected to grow from USD 2.71 billion in 2026 to USD 4.45 billion by 2034, registering a CAGR of 6.38% during the forecast period (2026-2034). North America dominated the central venous catheter market with a share of 41.56% in 2025.
A central venous catheter is a thin, flexible tube inserted into a large vein to provide direct access to the bloodstream. It is used to administer medications, fluids, nutrients, and blood products to collect blood samples. These catheters are tracked under HSN Code 9018 (instruments and appliances used in medical and surgical sciences) and SIC Code 3841 (surgical and medical instruments and apparatus).
The central venous catheter market demand is driven by high intensive care admissions, the need for long-term intravenous therapy, and the use of central venous access during complex medical procedures. Medical device manufacturers are developing catheters with antimicrobial coatings, improved insertion features, and designs that help reduce catheter-related infections.
Download a Free Sample To learn more about this report,
Development of Antimicrobial Catheter Coatings to Limit Device Related Infections
The central venous catheter market analysis shows a shift toward catheter surfaces with antimicrobial agents that help reduce microbial colonization. Coatings with chlorhexidine or silver-based compounds aim to inhibit microbial growth on catheter surfaces. These technologies address catheter infection prevention, especially in intensive care and long-term vascular access management settings.
Expansion of Tunneled and Implantable Catheter Designs for Long-Term Vascular Access
Central venous catheter manufacturers are refining tunneled catheters and implantable ports for patients who require repeated or prolonged vascular access. These devices place the access point beneath the skin or route the catheter through a subcutaneous tunnel, depending on the design.
Supply chain disruptions are expected to have a high impact on the central venous catheter market share due to its direct exposure to shortages of medical-grade polymers, catheter tubing, and specialized coatings. A capacity-constrained recovery is likely, as strict quality requirements can delay production. Supply chain constraints could reduce the growth rate from 6.38% to 4.88%, a decline of 1.50 percentage points. As supply conditions normalize, the central venous catheter market growth is expected to gradually return to 6.38%.
The central venous catheter market forecasts investment in catheter manufacturing, vascular access monitoring technologies, and devices designed to improve catheter placement and patient safety. In July 2026, Navi Medical Technologies completed a capital raise of AUD 6.8 million to support the US commercialization of its Neonav technology.
Demand for Safer Catheter Securement and Need for Multi-Lumen Catheters in Complex Treatments Drives Market
Healthcare providers are placing greater emphasis on secure catheter placement and proper maintenance to reduce complications during treatment. Advanced securement devices and catheter care systems help prevent accidental displacement, support site stability, and lower the risk of catheter-related infections. These benefits encourage hospitals to adopt improved catheter management solutions and support market demand.
Patients who require several medications, fluids, or therapies at the same time often need reliable vascular access. Multi-lumen catheters allow healthcare professionals to deliver different treatments through separate channels, reducing the need for multiple vascular access devices.
Catheter Placement Complexity and Material-Related Complications Restrain Market Expansion
Central venous catheter placement requires precise access to large blood vessels and careful positioning to avoid complications. Difficult insertion procedures can increase the risk of vessel injury, incorrect catheter placement, and pneumothorax, which may limit the use of these devices in certain clinical settings.
Some catheter materials can cause allergic reactions or fail to provide suitable durability under repeated clinical use. Material incompatibility and catheter damage can require device replacement or alternative product selection, increasing treatment costs.
Development of Central Venous Catheters for Extracorporeal Photopheresis and Remote Patient Monitoring Create Opportunities for Market Players
Extracorporeal photopheresis provides a specialized opportunity for central venous catheter manufacturers. This therapy requires reliable vascular access for blood collection and return during treatment. Manufacturers can develop catheters with suitable flow capacity and lumen configurations for patients who undergo repeated photopheresis sessions.
Remote patient monitoring offers another niche opportunity through central venous catheter systems with sensors or compatible accessories that help detect changes in catheter function. These solutions could support earlier identification of flow problems or pressure changes in selected care settings. Medical device companies can collaborate with monitoring technology developers to assess safe, clinically validated applications for long-term vascular access care.
Non-tunneled central venous catheters led the product type segment, accounting for a dominant share of 35.62% in 2025. This dominance is supported by their widespread use for short-term vascular access in hospital settings.
Peripherally inserted central catheters are projected to expand at a CAGR of 7.24% during the forecast period, driven by the demand for longer-term intravenous therapy and reliable vascular access.
Request Customizationto receive a tailored report.
Double lumen accounted for a dominant share of 36.84% in 2025 due to its ability to support the simultaneous administration of compatible medications and fluids through separate channels. This functionality makes double lumen catheters useful in critical care and other complex treatment settings.
Multi-lumen is anticipated to record the fastest growth at a CAGR of 7.11% during the forecast period, fueled by the demand for multiple simultaneous infusions and complex treatment regimens, which is expected to drive adoption.
In 2025, polyurethane dominated the market with a share of 57.46% in 2025, reflecting its flexibility, durability, and suitability for a wide range of vascular access procedures. These properties support its use across various hospital and clinical applications.
Silicone is expected to witness the fastest growth, registering a CAGR of 6.09% during the forecast period. Continued preference for materials that balance flexibility, strength, and performance is likely to sustain segment demand.
Drug administration had a share of 34.76% in 2025, supported by the widespread use of central venous catheters to deliver medications directly into the bloodstream. Their importance in intensive care and long-term treatment contributes to demand across healthcare settings.
Fluid and nutrition administration will expand to 6.43% CAGR during the forecast period, propelled by the demand for intravenous therapies and the treatment of patients with complex medical conditions.
Hospitals represented the largest market share at 68.54% in 2025, driven by the high volume of inpatient care, emergency procedures, and intensive care treatments requiring central venous access.
Ambulatory surgery centers are likely to grow at a CAGR of 7.28% during the forecast period due to the use of outpatient procedures and the need for effective vascular access in surgical care settings.
Speak to an Analystto discuss market opportunities.
The Asia Pacific central venous catheter market will expand to 8.22% CAGR, showcasing the fastest-growing regional growth.
Qingdao West Coast New Area Fifth People’s Hospital launched a dedicated peripherally inserted central catheter (PICC) clinic, offering catheter dressing changes and routine maintenance, including home nursing visits for patients who cannot travel to the hospital. These outpatient services create continued demand for central venous catheters.
The Indian Society of Critical Care Medicine identifies frequent blood sampling and measurement of central venous oxygen saturation as important applications of central venous catheters in critically ill patients. These diagnostic and monitoring needs sustain demand for reliable central venous access devices across Indian hospitals.
Japan’s National Cancer Center Hospital performs around 900 central venous port placements annually to provide vascular access for chemotherapy and blood sampling. The use of these ports helps reduce repeated needle sticks and supports patients requiring ongoing cancer treatment.
Unlock Regional Insightsto access country-level data, & regional trends.
Qingdao West Coast New Area Fifth People’s Hospital launched a dedicated peripherally inserted central catheter(PICC)clinic, offering catheter dressing changes and routine maintenance, including home nursing visits for patients who cannot travel to the hospital. These outpatient services create continued demand for central venous catheters.
Japan’s National Cancer Center Hospital performs around 900 central venous port placements annually, to provide vascular access for chemotherapy and blood sampling. The use of these ports helps reduce repeated needle sticks and supports patients requiring ongoing cancer treatment.
Europe's central venous catheter market is expected to experience a growth rate of 5.96% during the forecast period.
Reliable vascular access for intravenous fluids and nutritional support is contributing to UK central venous catheter market growth. Guy’s and St Thomas’ NHS Foundation Trust provides parenteral nutrition through central venous access devices, including PICC lines, Hickman lines, and implanted ports. These applications highlight the importance of central venous catheters in delivering fluids and essential nutrients to patients requiring specialized care.
Germany’s Society of Hematology and Medical Oncology recognizes the use of multi-lumen catheters and recommends collecting separate blood cultures from each lumen when a catheter-related infection is suspected. These clinical applications highlight the role of multi-lumen central venous catheter configurations.
The Latin America central venous catheter market is anticipated to record a growth rate of 6.73% during the forecast period. Mexico’s market is supported by the need for reliable vascular access to administer intravenous fluids, medications, and nutritional support to patients requiring hospital-based and specialized care. Brazil’s National Health Surveillance Agency (Anvisa)'s National Program for the Prevention and Control of Healthcare Associated Infections strengthens infection surveillance, increasing the importance of reliable central venous catheters.
The Middle East & Africa central venous catheter market is projected to achieve a growth rate of 7.01% during the forecast period. Sheikh Shakhbout Medical City in Abu Dhabi provides tunneled dialysis catheter placement, reflecting the role of these devices in dialysis care. South Africa’s National Department of Health practical manual also outlines measures to reduce catheter-associated bloodstream infections, reinforcing the need for reliable vascular access devices and infection control products in hospitals and ICUs.
The central venous catheter market competitive landscape is highly competitive, with established medical device manufacturers, vascular access specialists, and healthcare equipment providers. Key players such as BD, Teleflex, B. Braun Melsungen, Lepu Medical Technology, and ICU Medical are estimated to account for 40–45% of the global central venous catheter market share.
Established players compete mainly through catheter safety, infection prevention, product quality, and ease of insertion. Regional players in the central venous catheter market ecosystem focus on cost-effective catheter systems and specialized vascular access products.
July 2026: Teleflex secured a national purchasing agreement with Premier, expanding access to its Arrow-brand central venous catheters.
June 2026: BD’s CentroVena One Insertion System received an Innovative Technology contract from Vizient.
April 2026: Becton, Dickinson and Company commercially launched the CentroVena One Insertion System in the United States.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Experts
The Straits Research Team is a group of experienced researchers, analysts, and industry professionals dedicated to delivering reliable, insightful, and well-structured market intelligence. With expertise across multiple sectors and domains, the team combines extensive research, data analysis, and industry knowledge to provide a clear understanding of evolving markets and business environments.
The team focuses on identifying key market trends, emerging opportunities, technological developments, competitive landscapes, and changing industry dynamics. Through a thoughtful and research-driven approach, it aims to provide valuable insights that help businesses, investors, and decision-makers better understand their industries and make informed strategic decisions.
Bone Distractors Market Size, Forecast, Demand, Opportunities, 2034
Cordyceps Militaris Market Size, Share, Growth, Analysis, 2034
Ultrasound Devices Market Size, Share, Growth, Analysis, 2034
Autoclaves Market Size, Forecast, Demand, Opportunities, 2034
Blood Glucose Monitoring Devices Market Size, Forecast, Demand, Opportunities, 2034
We are featured on:
sales@straitsresearch.com